Inder Anand

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (230)

• Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
  European Heart Journal - Cardiovascular Pharmacotherapy 2025 DOI: 10.1093/ehjcvp/pvaf064
  +Save
• Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM‐HF and PARAGON‐HF
  Journal of the American Heart Association 2025 DOI: 10.1161/JAHA.124.037782
  +Save
• Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials
  Journal of the American Heart Association 2024 DOI: 10.1161/JAHA.123.032279
  +Save
• Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
  Circulation 2023 DOI: 10.1161/CIRCULATIONAHA.122.063642
  +Save
• Stroke in patients with heart failure and reduced or preserved ejection fraction
  European Heart Journal 2023 DOI: 10.1093/eurheartj/ehad338
  +Save
• Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation
  Circulation: Heart Failure 2023 DOI: 10.1161/CIRCHEARTFAILURE.122.010377
  +Save
• Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
  European Heart Journal 2023 DOI: 10.1093/eurheartj/ehac801
  +Save
• Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes
  Journal of the American Heart Association 2022 DOI: 10.1161/JAHA.121.023743
  +Save
• Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
  David D. Berg, Kieran F. Docherty, Naveed A. Sattar +17 more
  Circulation 2022 DOI: 10.1161/CIRCULATIONAHA.121.057852
  +Save
• Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
  European Heart Journal 2021 DOI: 10.1093/eurheartj/ehab499
  +Save
• Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
  Journal of the American Heart Association 2021 DOI: 10.1161/JAHA.121.022069
  +Save
• Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
  Circulation 2021 DOI: 10.1161/CIRCULATIONAHA.121.056824
  +Save
• Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia
  Circulation: Cardiovascular Quality and Outcomes 2021 DOI: 10.1161/CIRCOUTCOMES.120.006962
  +Save
• Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN‐HF Registry
  Janice Y. Chyou, Wan Ting Tay, Inder S. Anand +11 more
  Journal of the American Heart Association 2021 DOI: 10.1161/JAHA.120.017932
  +Save
• Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
  Hypertension 2021 DOI: 10.1161/HYPERTENSIONAHA.120.16277
  +Save
• Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction
  Circulation 2021 DOI: 10.1161/CIRCULATIONAHA.120.051783
  +Save
• Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
  Pardeep S. Jhund, Scott David Solomon, Kieran F. Docherty +24 more
  Circulation 2021 DOI: 10.1161/CIRCULATIONAHA.120.050391
  +Save
• Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
  Circulation 2020 DOI: 10.1161/CIRCULATIONAHA.120.047480
  +Save
• How I treat anemia in heart failure
  Blood 2020 DOI: 10.1182/blood.2019004004
  +Save
• Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF
  Alice M. Jackson, Pooja Dewan, Inder S. Anand +27 more
  Circulation 2020 DOI: 10.1161/CIRCULATIONAHA.120.047077
  +Save